Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  TIL 1383I T cell receptor-transduced autologous T cells
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Genetically Engineered T Cells and Low-Dose Aldesleukin After Combination Chemotherapy in Treating Patients With Metastatic Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LU# 203732, NCI-2012-02875, 203732, 203732092111, P01CA154778, R44CA126461, 9358, NCT01586403
Start Over